Skip to main content
Equibles

Rathbones Group PLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1351991 Liverpool, X0
Back to XENE Full portfolio

Position in XENE

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$1,398,299
+$22,122 QoQ
Shares Held
23,166
-2.1% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#164
of 315 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rathbones Group PLC holds $10,663,603 across 18 Biotechnology names. XENE ranks #3 (13.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PTCT
Ptc Therapeutics, Inc.
 23,500 $1,916,895
2 IBRX
ImmunityBio, Inc.
 163,220 $1,428,991
3 XENE
Xenon Pharmaceuticals Inc.
This page 		23,166 $1,398,299
4 ORMP
Oramed Pharmaceuticals Inc.
 233,018 $1,120,816
5 DFTX
Definium Therapeutics, Inc.
 22,800 $1,072,512
6 CORT
Corcept Therapeutics Inc
 11,790 $1,025,140
7 MRNA
Moderna, Inc.
 9,474 $663,464
8 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,044 $518,586

All Filings in XENE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,398,299 23,166
2026-03-31 $1,376,177 23,666
2025-12-31 $1,060,710 23,666
2025-09-30 $950,189 23,666
2025-06-30 $740,745 23,666
2025-03-31 $793,994 23,666
2024-12-31 $927,707 23,666
2024-09-30 $931,730 23,666
2024-06-30 $922,737 23,666
2024-03-31 $1,018,821 23,666
2023-12-31 $1,090,055 23,666
2023-09-30 $808,430 23,666